(NASDAQ: ASTH) Astrana Health's forecast annual revenue growth rate of 28.01% is forecast to beat the US Medical Care Facilities industry's average forecast revenue growth rate of 4.46%, and it is also forecast to beat the US market's average forecast revenue growth rate of 25.15%.
Astrana Health's revenue in 2025 is $2,250,574,000.On average, 12 Wall Street analysts forecast ASTH's revenue for 2025 to be $183,489,983,376, with the lowest ASTH revenue forecast at $174,800,418,016, and the highest ASTH revenue forecast at $191,955,301,888. On average, 12 Wall Street analysts forecast ASTH's revenue for 2026 to be $233,104,598,496, with the lowest ASTH revenue forecast at $215,501,220,928, and the highest ASTH revenue forecast at $249,138,248,128.
In 2027, ASTH is forecast to generate $256,033,838,704 in revenue, with the lowest revenue forecast at $238,598,646,272 and the highest revenue forecast at $277,281,227,552.